Literature DB >> 23551777

Embolisation of hypervascular bone tumours: a pictorial essay with literature review.

Vince Lau1, Michael Sun, Ferdinand Chu.   

Abstract

Bone tumours, either primary or secondary, can present in various debilitating manners, including pain and pathological fracture. The situation is particularly problematic when the tumours are hypervascular, and located in regions where a high risk of neurological compromise is anticipated during operation, such as in the spine or sacrum. In such situations, bone tumour embolisation is a useful and effective adjunctive treatment for reducing intra-operative blood loss. This is particularly relevant in primary bone tumours such as giant cell tumours and metastatic renal cell and thyroid tumours. With a proper pre-embolisation angiogram and knowledge of anatomy, careful selective cannulation of the arterial supplies and experience in using embolic agents, the risks of non-target embolisation can be kept to minimum and the best result achieved.
© 2012 The Authors. Journal of Medical Imaging and Radiation Oncology © 2012 The Royal Australian and New Zealand College of Radiologists.

Entities:  

Mesh:

Year:  2012        PMID: 23551777     DOI: 10.1111/j.1754-9485.2012.02444.x

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  3 in total

1.  Complete resection of a huge hypervascular inflammatory myofibroblastic tumor in right hemithorax after embolization.

Authors:  Kyu-Nam Kim; Dong-Won Kim
Journal:  World J Pediatr       Date:  2016-06-10       Impact factor: 2.764

Review 2.  Isolated Avulsion Fracture of the Lesser Trochanter in Adults.

Authors:  Hwan Seong Cho; Young-Kyun Lee; Byung-Ho Yoon; Jung-Wee Park; Yong-Chan Ha; Kyung-Hoi Koo
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

3.  Transcatheter embolization with Squid, combined with other embolic agents or alone, in different abdominal diseases: a single-center experience in 30 patients.

Authors:  Massimo Venturini; Carolina Lanza; Paolo Marra; Anna Colarieti; Marta Panzeri; Luigi Augello; Simone Gusmini; Marco Salvioni; Francesco De Cobelli; Alessandro Del Maschio
Journal:  CVIR Endovasc       Date:  2019-02-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.